CELLFORCURE Trademark

Trademark Overview


On Wednesday, October 12, 2011, a trademark application was filed for CELLFORCURE with the United States Patent and Trademark Office. The USPTO has given the CELLFORCURE trademark a serial number of 79106607. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, June 23, 2023. This trademark is owned by LABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES. The CELLFORCURE trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Insurance & Financial Services, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Cryopreservation, for autologous or allogenic therapy purposes, of human tissues and their by-products and preparations for cell therapy; custom manufacturing for others, namely, manufacturing of pharmaceutical [ and veterinary ] preparations for health care, for the treatment of humans [ and animals ] suffering from diseases treated by cell therapy or regenerative medicine products, particularly medicines for human purposes including medicines for experimental purposes, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies

Pharmaceutical [ and veterinary ] preparations for the treatment of humans [ and animals ] suffering from diseases treated by cell therapy or regenerative medicine products [ ; sanitary preparations for medical purposes; medical plasters; material for dental fillings and dental impressions; all purpose disinfectants ]

[ Financial and real estate affairs in every type of financial, real estate or securities-related operation and in all commercial or industrial firms in the field of health, namely, financial consultancy, financial analysis, capital accumulation and investment, real estate appraisal; real estate brokerage, namely, real estate acquisition services for business assets; real estate brokerage, namely, rental of commercial property; real estate brokerage, namely, leasing and management for others of commercial property; rental, leasing and management of real estate, particularly of all commercial properties in the nature of facilities, businesses, factories and workshops in the health sector ]

[ Retail store services featuring tissues and their by-products and preparations for cell therapy for autologous or allogenic therapy purposes; marketing services; importing and exporting agencies for health products, particularly of medicines for human purposes including medicines for experimental purposes, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies ]

[ Legal services, namely, advice and assistance for public laboratories and companies, particularly those in the medical and health sectors, on state and federal regulatory compliance requirements; legal services, namely, licensing of patented or non-patented goods, procedures and inventions in the field of health ]

[ Advice and assistance, namely, ] providing information in the field of cell therapy and regenerative medicine for public laboratories and companies, particularly those in the medical and health sectors

Research and development, for autologous or allogenic therapy purposes, for tissues and their by-products and preparations for cell therapy; research and development of health preparations, particularly of medicines for human purposes including medicines for experimental purposes, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies; scientific studies relating to the health sector in the field of cell therapy and regenerative medicine
cellforcure

General Information


Serial Number79106607
Word MarkCELLFORCURE
Filing DateWednesday, October 12, 2011
Status709 - CANCELLED - SECTION 71
Status DateFriday, June 23, 2023
Registration Number4255776
Registration DateTuesday, December 11, 2012
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2012

Trademark Statements


Goods and ServicesCryopreservation, for autologous or allogenic therapy purposes, of human tissues and their by-products and preparations for cell therapy; custom manufacturing for others, namely, manufacturing of pharmaceutical [ and veterinary ] preparations for health care, for the treatment of humans [ and animals ] suffering from diseases treated by cell therapy or regenerative medicine products, particularly medicines for human purposes including medicines for experimental purposes, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies
Goods and ServicesPharmaceutical [ and veterinary ] preparations for the treatment of humans [ and animals ] suffering from diseases treated by cell therapy or regenerative medicine products [ ; sanitary preparations for medical purposes; medical plasters; material for dental fillings and dental impressions; all purpose disinfectants ]
Pseudo MarkCELL FOR CURE
Goods and Services[ Financial and real estate affairs in every type of financial, real estate or securities-related operation and in all commercial or industrial firms in the field of health, namely, financial consultancy, financial analysis, capital accumulation and investment, real estate appraisal; real estate brokerage, namely, real estate acquisition services for business assets; real estate brokerage, namely, rental of commercial property; real estate brokerage, namely, leasing and management for others of commercial property; rental, leasing and management of real estate, particularly of all commercial properties in the nature of facilities, businesses, factories and workshops in the health sector ]
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Services[ Retail store services featuring tissues and their by-products and preparations for cell therapy for autologous or allogenic therapy purposes; marketing services; importing and exporting agencies for health products, particularly of medicines for human purposes including medicines for experimental purposes, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies ]
Goods and Services[ Legal services, namely, advice and assistance for public laboratories and companies, particularly those in the medical and health sectors, on state and federal regulatory compliance requirements; legal services, namely, licensing of patented or non-patented goods, procedures and inventions in the field of health ]
Goods and Services[ Advice and assistance, namely, ] providing information in the field of cell therapy and regenerative medicine for public laboratories and companies, particularly those in the medical and health sectors
Goods and ServicesResearch and development, for autologous or allogenic therapy purposes, for tissues and their by-products and preparations for cell therapy; research and development of health preparations, particularly of medicines for human purposes including medicines for experimental purposes, biological products for experimental purposes, preparations for cell therapy and medicines for innovative therapies; scientific studies relating to the health sector in the field of cell therapy and regenerative medicine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 23, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status CodeG - NOT AVAILABLE
Class Status DateThursday, June 13, 2019
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status CodeG - NOT AVAILABLE
Class Status DateThursday, June 13, 2019
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 23, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 23, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 23, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status CodeG - NOT AVAILABLE
Class Status DateThursday, June 13, 2019
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCELLFORCURE
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressFR

Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLES ULIS F-91940
FR

Party NameLABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressF-91940 LES ULIS
FR

Party NameLABORATOIRE FRANCAIS DU; FRACTIONNEMENT; ET DES BIOTECHNOLOGIES
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressF-91940 LES ULIS
FR

Trademark Events


Event DateEvent Description
Thursday, December 22, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, December 28, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 3, 2012APPLICATION FILING RECEIPT MAILED
Tuesday, January 31, 2012ASSIGNED TO EXAMINER
Tuesday, February 7, 2012NON-FINAL ACTION WRITTEN
Wednesday, February 8, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 9, 2012REFUSAL PROCESSED BY MPU
Friday, February 10, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 6, 2012REFUSAL PROCESSED BY IB
Wednesday, July 25, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 25, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 25, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 14, 2012EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 14, 2012EXAMINERS AMENDMENT E-MAILED
Tuesday, August 14, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 14, 2012EXAMINER'S AMENDMENT ENTERED
Tuesday, August 14, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 22, 2012ASSIGNED TO LIE
Thursday, August 23, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 5, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 5, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 5, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, September 25, 2012PUBLISHED FOR OPPOSITION
Tuesday, September 25, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2012NOTIFICATION PROCESSED BY IB
Tuesday, December 11, 2012REGISTERED-PRINCIPAL REGISTER
Monday, March 11, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, March 15, 2013FINAL DISPOSITION PROCESSED
Friday, March 15, 2013FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, April 16, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 21, 2014NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 27, 2015NEW REPRESENTATIVE AT IB RECEIVED
Monday, December 11, 2017COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, June 10, 2019TEAS SECTION 71 & 15 RECEIVED
Thursday, June 13, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 13, 2019REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, June 13, 2019NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Friday, December 27, 2019CHANGE OF OWNER RECEIVED FROM IB
Thursday, February 13, 2020PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, May 7, 2020INVALIDATION PROCESSED
Thursday, May 7, 2020PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, June 12, 2020PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, September 24, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 5, 2021INTERNATIONAL REGISTRATION RENEWED
Saturday, December 11, 2021COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Tuesday, July 26, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 26, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 26, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 26, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, July 26, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 26, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 23, 2023CANCELLED SECTION 71
Friday, February 23, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, March 2, 2024INVALIDATION PROCESSED
Saturday, March 2, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, April 1, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Friday, September 20, 2024NEW REPRESENTATIVE AT IB RECEIVED